Supporting the Company's Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine

- SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round exceeding $110 million, led by major health-tech fund and followed by strategic industry leader

- Company demonstrates solidity of its business model with banks joining in the round

- Didier Hirsch, former CFO at Agilent and Board member at Logitech, joins the company's Board of Directors and will chair its Audit Committee

LAUSANNE, Switzerland and BOSTON, October 1, 2020-- SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the closing …